Access to Innovation
Wellspring Announces Japan Technology Group as a Channel Partner for Japan Market
Wellspring Worldwide, the leader in software for technology transfer and corporate innovation management, today appointed Japan Technology Group (JTG) as a strategic channel partner in Japan.
Contract to research and identify European industrial technologies of high cooperation and business potential for Japan.
Japan Technology Group as member of the International Consortium has been awarded a contract to research and identify European industrial technologies of high cooperation and business potential for Japan.
JAPAN TECHNOLOGY GROUP, Inc. has signed a MOU with I-DEALS INNOVATION &
TECHNOLOGY VENTURING SERVICES, S.L.U ( everis Group, subsidiary of the NTT Data Group)
What people are saying about JTG
“JTG has proven to be very dependable and as advertised, they are extremely well connected to the research community in Japan. Their core expertise and approach to doing business are in alignment with our objectives. As a result, we have been able to establish several strategic relationships and collaboration opportunities.”
University of Hawai‘i
Director Business Development, Office of the Vice President for Research and Innovation
Sample list of corporations which provide technological needs to JTG.
（Listed in alphabetical order）
Abiogen Pharma, Ablynx, AERAS Global TB Vaccine Foundation, Affitech USA, Agilent Technologies, Air Products & Chemicals, Alfresa Pharma Corporation, Amgen, Anatech Ltd., AntiCancer, Inc., Aphton, ApoLife, Applera Corporation, Ariston Pharmaceuticals, ArtiSoft, Astellas Pharma, Astellas Pharma Europe, AstraZeneca, AstraZeneca K.K.(Japan R&D), AstraZeneca Pharmaceuticals LP, Athena Diagnostics, BASF AG, Bausch & Lomb AG, Bayer HealthCare LLC, Bayer Crop Science, Beacon Pharmaceuticals, BioInvent International AB, Biological Targets, BioMarin, Biomira, Biotech Park, Biovail, Biovitrum Biopharmaceuticals, birchbob, Boehringer Ingelheim, Boehringer Laboratories, BTG plc, Cargill, Cenamps, Central Life Sciences, Chemicon International, Chiron, Cima Labs, Clean Diesel Technologies, Colgate Palmolive Company, Corium International, Curacyte AG, Debiopharm SA & Debioinnovation, Diversa, DuPont, Dyax, Dynogen, ebadu ventures limited, Ecolab, Elementis, Eli Lilly, F.Hoffman-La Roche, Fresenius Kabi, Gaylord Chemical Corp., GE Healthcare, Genentech, General Mills, Genetrix, Genzyme, GlaxoSmithKline, Goodlife Healthcare, GSK Consumer Healthcare, Helsinn Healthcare, Hitachi Americas, HSS Ventures, iCo Therapeutics, Immune Control, Innovata plc, InterMolecular, Invitrogen Corporation, Johnson & Johnson, Juelich Fine Chemicals, KMG Japan, Kubota Research Associates, Kuros Biosurgery, LabCorp, Lampire Biological Laboratories, Leiras Finland, Life Technologies Corporation, L’Oreal USA Products, Lorus Therapeutics, March Plasma Systems, Maxygen, MedImmune, Menarini Biotech, Merck & Co, Merck Frosst Canada, Merz, Microsoft Corporation, Milliken Chemical, Millipore, Millwrights, Monsanto, MOSAID Technologies Incorporated, NichiBei Bio, NineSigma, Novartis Consumer Healthcare, NovaThera, Novo Nordisk A/S, Novus Biologicals, NTTC, Office of Law Enforcement Techn. Commercialia, OM THANIKAI INDUSTRIES, Pain Therapeutics, Pfizer Consumer Healthcare, Pfizer, Inc, Pharmacopeia, philogene, Pierre Fabre SA, Plant Biosciences (PBL), PPG Industries, Praxair, Procter & Gamble, ProCyte Corporation, Promega, QLT, RCT BioVentures, Reckitt Benckiser , Replizyme, Roche, Sanofi-Aventis, Sanofi-Pasteur, SC Johnson & Son, SemBioSys Genetics, seriatina.com, Signet Laboratories, SingVax, SkinMedica, SSL International, StoneBridge Pharma, Sunesis, Technic, The Dow Chemical Company, Two River, Upstate USA, Vincogen Corp., Vishay Intertechnologies, Ward Industries, Ward Industries, WellGen, WorldTech, Wyeth Pharmaceuticals, yet2.com, Zephyr Sciences, Zobele
ACADEMIA & START-UP
JTG provides opportunities of direct access to hundreds of Japanese companies and research institutions who are seeking for a new technology and improved technique as well as potential opportunity for collaboration.
Technology Transfer Service
J A P A N T E C H N O L O G Y G R O U P S E R V I C E S
• University TTOs and research institutions
• Researchers and inventors
• Start-ups and small companies
• Technology providers and holders
We offer services for:
We leverage our extensive network in Japan to enhance and accelerate communication and collaboration in order to promote, foster and add value to technology and intellectual property transfer and R&D.
Partnering with Japanese companies
With our network of corporate innovation buyers and knowledge of market needs in Japan, JTG provide effective partnering opportunities with targeted companies.
• Market validation & assessment
• Identify licensing & commercialization opportunities
• Joint or funded research and development
• Contract negotiation and execution
Direct access to Japanese industries and academia
Patent Management & Legal Service
JTG provide IP related legal services in Japan based on our strong expertise in intellectual property law in Japan.
Protecting assets in Japan
With over 10 years of specialized IP management expertise, you can trust us to protect your promising researches and technologies especially in Japanese market. Importantly we also offer expert advice on further potential development routes and access to funding in Japan.
Legal services in Japan
We offer a broad range of legal support in the areas of IP law and overall legal matters in Japan. Our services include managing IP portfolio as well as providing legal consultation related to technology transfer in Japan.
We also provide:
(Omori & Yaguchi, LLC)
Contact / Inquiries
Japan Technology Group, Inc.